OmanDocSign in

Curriculum · Cardiovascular and Hypertension

Lifestyle and dietary management of hypertension

What it is

Lifestyle modification is the non-pharmacological half of hypertension management, and DASH stands for Dietary Approaches to Stop Hypertension. Lifestyle modifications addressing diet, physical activity, and weight are important in the treatment of hypertension, particularly for African-American and Hispanic patients. Each modification has an approximate SBP reduction:

The physical activity is regular aerobic physical activity such as brisk walking, at least 30 min per day, most days of the week. The alcohol moderation is no more than 2 drinks per day in most men, for example 24 oz beer, 10 oz wine, or 3 oz 80-proof whiskey, and no more than 1 drink per day in women and lighter weight persons. For overall cardiovascular risk reduction, stop smoking. The effects of these modifications are dose and time dependent, and could be greater for some individuals.

How it is treated

The recommended lifestyle modifications in hypertension:

The exercise advice is given in numbers. For pre-hypertensive individuals or for hypertensive patients, prescribe the accumulation of 30 to 60 minutes of moderate intensity dynamic exercise, such as walking, jogging, cycling or swimming, four to seven days per week, in addition to the routine activities of daily living; higher intensities of exercise are no more effective. Weight goes with it: maintenance of a healthy body weight, body mass index 18.5 to 24.9 and waist circumference less than 94 cm for men and less than 80 cm for women, through a multidisciplinary approach of dietary education, increased physical activity and behavioral intervention. The national guideline sets the dietary objectives in numbers, and those are the ones to carry. Obese and overweight individuals should accomplish a 10% weight loss to decrease their blood pressure. Sodium intake is to be reduced to less than 1,500 mg per day and potassium intake increased to more than 4,700 mg per day, with a DASH-type meal plan. The other objectives are to prevent, delay or treat the long-term complications of hypertension, to educate the patient on the role of nutrition, to recommend a nutritionally adequate diet balanced against physical activity, to achieve optimal blood lipid levels, and to limit caffeine and alcoholic beverages. Where the two differ on salt, hold both: the older page gives no more than 100 mmol per day, that is 2.4 g of sodium or 6 g of sodium chloride, while the national guideline gives less than 1,500 mg per day, and the national guideline is the newer and the one worked to here. The DASH Eating Plan itself is designed to reduce sodium, to include fruits, vegetables and whole grains, and to limit fat intake; it is high in potassium, calcium, magnesium and fiber. The same guideline also gives the salt target as a range: reduce dietary sodium intake to between 1500 mg and 2400 mg, that is 65 to 100 mmol, per day, by eating low sodium foods. The recommended amount of dietary fiber is 20 to 35 grams per day, or 14 gm per 1000 kcal, and its sources are fruits and vegetables, which are rich sources of vitamins and minerals and of beneficial non-nutrient substances including plant sterols, flavonoids and other antioxidants. Potassium intake from food is increased to at least 90 mmol/day, that is 3510 mg/day; the guideline carries two potassium targets, this one and the more than 4,700 mg per day set out above, and names neither as the one in force. Supplementation of potassium, calcium and magnesium is not recommended for the prevention or treatment of hypertension, so the increase is to come from food alone. And the plan itself is restricted: the DASH diet is not recommended for individuals with stage 3 to 5 chronic kidney disease, that is with an estimated glomerular filtration rate of <60. Lifestyle modification is not the whole of treatment, and the drug that goes with it is not the same for every patient. When antihypertensive drugs are also required, the best options may vary according to the racial and ethnic background of the patient, and the presence or absence of comorbid conditions is also important to consider. For African-Americans, thiazide diuretics and calcium channel blockers, both as monotherapy and as a component in multidrug regimens, are more effective in lowering blood pressure than ACE inhibitors, angiotensin II receptor blockers, or beta blockers, and should be considered as first-line options over the other classes unless a comorbid condition is present that would be better addressed with a different class of drugs. Racial or ethnic background should not be the basis for the exclusion of any drug class when multidrug regimens are required to reach treatment goals.